These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
258 related articles for article (PubMed ID: 10852350)
21. Prolonged extracellular signal-regulated kinase 1/2 activation during fibroblast growth factor 1- or heregulin beta1-induced antiestrogen-resistant growth of breast cancer cells is resistant to mitogen-activated protein/extracellular regulated kinase kinase inhibitors. Thottassery JV; Sun Y; Westbrook L; Rentz SS; Manuvakhova M; Qu Z; Samuel S; Upshaw R; Cunningham A; Kern FG Cancer Res; 2004 Jul; 64(13):4637-47. PubMed ID: 15231676 [TBL] [Abstract][Full Text] [Related]
22. Protein kinase C alpha trigger Ras and Raf-independent MEK/ERK activation for TPA-induced growth inhibition of human hepatoma cell HepG2. Wen-Sheng W Cancer Lett; 2006 Jul; 239(1):27-35. PubMed ID: 16169661 [TBL] [Abstract][Full Text] [Related]
24. Requirement for Ras/Raf/ERK pathway in naringin-induced G1-cell-cycle arrest via p21WAF1 expression. Kim DI; Lee SJ; Lee SB; Park K; Kim WJ; Moon SK Carcinogenesis; 2008 Sep; 29(9):1701-9. PubMed ID: 18296682 [TBL] [Abstract][Full Text] [Related]
25. Retinoic acid-induced RB (retinoblastoma) hypophosphorylation enhanced by CGP 52411 (4,5-dianilinophthalimide), an EGF family tyrosine kinase receptor inhibitor. Yen A; Soong S Eur J Cell Biol; 1996 Apr; 69(4):327-34. PubMed ID: 8741214 [TBL] [Abstract][Full Text] [Related]
26. Sorafenib inhibits growth and mitogen-activated protein kinase signaling in malignant peripheral nerve sheath cells. Ambrosini G; Cheema HS; Seelman S; Teed A; Sambol EB; Singer S; Schwartz GK Mol Cancer Ther; 2008 Apr; 7(4):890-6. PubMed ID: 18413802 [TBL] [Abstract][Full Text] [Related]
27. A MAPK-positive feedback mechanism for BLR1 signaling propels retinoic acid-triggered differentiation and cell cycle arrest. Wang J; Yen A J Biol Chem; 2008 Feb; 283(7):4375-86. PubMed ID: 18006504 [TBL] [Abstract][Full Text] [Related]
29. Genistein induces G2/M cell cycle arrest via stable activation of ERK1/2 pathway in MDA-MB-231 breast cancer cells. Li Z; Li J; Mo B; Hu C; Liu H; Qi H; Wang X; Xu J Cell Biol Toxicol; 2008 Oct; 24(5):401-9. PubMed ID: 18224451 [TBL] [Abstract][Full Text] [Related]
30. Dasatinib synergizes with ATRA to trigger granulocytic differentiation in ATRA resistant acute promyelocytic leukemia cell lines via Lyn inhibition-mediated activation of RAF-1/MEK/ERK. Ding M; Weng XQ; Sheng Y; Wu J; Liang C; Cai X Food Chem Toxicol; 2018 Sep; 119():464-478. PubMed ID: 29097117 [TBL] [Abstract][Full Text] [Related]
31. Retinoic acid-induced neuritogenesis of human neuroblastoma SH-SY5Y cells is ERK independent and PKC dependent. Miloso M; Villa D; Crimi M; Galbiati S; Donzelli E; Nicolini G; Tredici G J Neurosci Res; 2004 Jan; 75(2):241-252. PubMed ID: 14705145 [TBL] [Abstract][Full Text] [Related]
32. Oncogenic tyrosine kinase NPM/ALK induces activation of the MEK/ERK signaling pathway independently of c-Raf. Marzec M; Kasprzycka M; Liu X; Raghunath PN; Wlodarski P; Wasik MA Oncogene; 2007 Feb; 26(6):813-21. PubMed ID: 16909118 [TBL] [Abstract][Full Text] [Related]
33. 6-Formylindolo (3,2-b)carbazole (FICZ) enhances retinoic acid (RA)-induced differentiation of HL-60 myeloblastic leukemia cells. Bunaciu RP; Yen A Mol Cancer; 2013 May; 12():39. PubMed ID: 23656719 [TBL] [Abstract][Full Text] [Related]
34. A retinoic acid receptor beta/gamma-selective prodrug (tazarotene) plus a retinoid X receptor ligand induces extracellular signal-regulated kinase activation, retinoblastoma hypophosphorylation, G0 arrest, and cell differentiation. Yen A; Fenning R; Chandraratna R; Walker P; Varvayanis S Mol Pharmacol; 2004 Dec; 66(6):1727-37. PubMed ID: 15383624 [TBL] [Abstract][Full Text] [Related]
35. Interferon-alpha2b reduces phosphorylation and activity of MEK and ERK through a Ras/Raf-independent mechanism. Romerio F; Riva A; Zella D Br J Cancer; 2000 Aug; 83(4):532-8. PubMed ID: 10945503 [TBL] [Abstract][Full Text] [Related]
36. Akt regulates vitamin D3-induced leukemia cell functional differentiation via Raf/MEK/ERK MAPK signaling. Wang J; Zhao Y; Kauss MA; Spindel S; Lian H Eur J Cell Biol; 2009 Feb; 88(2):103-15. PubMed ID: 19058874 [TBL] [Abstract][Full Text] [Related]
37. Superoxide anion-dependent Raf/MEK/ERK activation by peroxisome proliferator activated receptor gamma agonists 15-deoxy-delta(12,14)-prostaglandin J(2), ciglitazone, and GW1929. Huang WC; Chio CC; Chi KH; Wu HM; Lin WW Exp Cell Res; 2002 Jul; 277(2):192-200. PubMed ID: 12083801 [TBL] [Abstract][Full Text] [Related]
38. Activation and role of MAP kinase-dependent pathways in retinal pigment epithelial cells: ERK and RPE cell proliferation. Hecquet C; Lefevre G; Valtink M; Engelmann K; Mascarelli F Invest Ophthalmol Vis Sci; 2002 Sep; 43(9):3091-8. PubMed ID: 12202534 [TBL] [Abstract][Full Text] [Related]
39. Mitogen-activated protein kinase is required for bryostatin 1-induced differentiation of the human acute lymphoblastic leukemia cell line Reh. Wall NR; Mohammad RM; Al-Katib AM Cell Growth Differ; 2001 Dec; 12(12):641-7. PubMed ID: 11751459 [TBL] [Abstract][Full Text] [Related]
40. Nuclear Raf-1 kinase regulates the CXCR5 promoter by associating with NFATc3 to drive retinoic acid-induced leukemic cell differentiation. Geil WM; Yen A FEBS J; 2014 Feb; 281(4):1170-80. PubMed ID: 24330068 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]